Navalesi R, Pilo A, Ferrannini E
J Clin Invest. 1978 Jan;61(1):197-208. doi: 10.1172/JCI108918.
The studies so far reported on the metabolic clearance rate of insulin in human diabetes mellitus have given conflicting results, probably because they have been conducted on few patients and have used a variety of experimental techniques and data treatments. We investigated the kinetics of insulin distribution and degradation in 35 normal subjects and in 42 nonketotic, nonobese, overtly diabetic patients, of whom 26 were above 40 yr old and 16 were 40 yr old or less at diagnosis. The design of the study combined (a) the use of a tracer to perturb minimally the steady state and to avoid glucose infusion; (b) the preparation of purified [(125)I]-monoiodoinsulin, which has a metabolic behavior similar to that of native insulin; and (c) noncompartmental analysis of the plasma immunoprecipitable (125)I-insulin disappearance curves, which were recorded for 2 h after pulse i.v. injection of the tracer.Metabolic clearance rate was found to be similar in diabetics (404+/-18 ml/min.m(2), mean+/-SEM) and in normals (420+/-14), although the latter-onset patients had slightly, if not significantly, lower metabolic clearance rate values than the earlier-onset diabetics (385+/-19 and 443+/-36, respectively). The initial distribution volume of the hormone also did not significantly differ in diabetics and normals and was similar to plasma volume. The reentry rate into the initial distribution volume of the hormone and the total, plasma-equivalent distribution volume of insulin were both significantly raised in diabetics (251+/-12 ml/min.m(2) and 10.3+/-0.5 liters/m(2)) in comparison with normals (195+/-8 and 7.5+/-0.3). The posthepatic delivery rate of insulin was found to be slightly raised in later-onset diabetics (194+/-20 mU/h.m(2)), but somewhat reduced in earlier-onset diabetics (133+/-15) in comparison with normals (172+/-14); these differences reflected the different basal plasma insulin concentrations in these three groups. Chronic treatment with oral hypoglycemic drugs, age, duration of the disease, and degree of metabolic control appeared to have only little effect on the kinetics of insulin.On the basis of these results, we conclude that insulin-independent adult diabetics show, already in the fasting state, a combination of insulin resistance and insulin deficiency and a derangement in insulin distribution, the precise significance of which is uncertain.
迄今为止所报道的关于人类糖尿病患者胰岛素代谢清除率的研究结果相互矛盾,这可能是因为这些研究针对的患者数量较少,且采用了多种实验技术和数据处理方法。我们研究了35名正常受试者以及42名非酮症、非肥胖、明显糖尿病患者体内胰岛素的分布和降解动力学,其中26名患者在诊断时年龄超过40岁,16名患者在诊断时年龄为40岁或更小。该研究设计结合了以下几点:(a)使用示踪剂对稳态的干扰最小,并避免输注葡萄糖;(b)制备纯化的[(125)I] - 单碘胰岛素,其代谢行为与天然胰岛素相似;(c)对静脉注射示踪剂后2小时内记录的血浆免疫沉淀(125)I - 胰岛素消失曲线进行非房室分析。结果发现,糖尿病患者(404±18 ml/min·m²,均值±标准误)和正常受试者(420±14)的代谢清除率相似,不过后起病的患者代谢清除率值略低于(若差异不显著)早发糖尿病患者(分别为385±19和443±36)。激素的初始分布容积在糖尿病患者和正常受试者中也无显著差异,且与血浆容积相似。与正常受试者(195±8和7.5±0.3)相比,糖尿病患者体内激素重新进入初始分布容积的速率以及胰岛素的总血浆等效分布容积均显著升高(分别为251±12 ml/min·m²和10.3±0.5升/m²)。发现晚发糖尿病患者胰岛素的肝后输送速率略有升高(194±20 mU/h·m²),但早发糖尿病患者的该速率与正常受试者(172±14)相比有所降低(133±15);这些差异反映了这三组患者基础血浆胰岛素浓度的不同。口服降糖药的长期治疗、年龄、病程以及代谢控制程度似乎对胰岛素动力学影响甚微。基于这些结果,我们得出结论,非胰岛素依赖型成年糖尿病患者在空腹状态下就已表现出胰岛素抵抗和胰岛素缺乏以及胰岛素分布紊乱的综合情况,其确切意义尚不确定。